ALNFL logo

NFL Biosciences ENXTPA:ALNFL Stock Report

Last Price

€2.82

Market Cap

€22.9m

7D

-7.8%

1Y

3.7%

Updated

26 Mar, 2024

Data

Company Financials +

ALNFL Stock Overview

NFL Biosciences SA, a biotechnology company, develops natural addiction withdrawal solutions for smokers.

ALNFL fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

NFL Biosciences SA Competitors

Price History & Performance

Summary of all time highs, changes and price drops for NFL Biosciences
Historical stock prices
Current Share Price€2.82
52 Week High€3.32
52 Week Low€0.94
Beta0
1 Month Change38.57%
3 Month Change98.59%
1 Year Change3.68%
3 Year Changen/a
5 Year Changen/a
Change since IPO-24.19%

Recent News & Updates

Recent updates

Shareholder Returns

ALNFLFR BiotechsFR Market
7D-7.8%-0.2%-0.4%
1Y3.7%-1.8%10.6%

Return vs Industry: ALNFL exceeded the French Biotechs industry which returned -2.2% over the past year.

Return vs Market: ALNFL underperformed the French Market which returned 10.1% over the past year.

Price Volatility

Is ALNFL's price volatile compared to industry and market?
ALNFL volatility
ALNFL Average Weekly Movement19.4%
Biotechs Industry Average Movement5.8%
Market Average Movement4.3%
10% most volatile stocks in FR Market10.0%
10% least volatile stocks in FR Market2.2%

Stable Share Price: ALNFL's share price has been volatile over the past 3 months.

Volatility Over Time: ALNFL's weekly volatility has increased from 14% to 19% over the past year.

About the Company

FoundedEmployeesCEOWebsite
2006n/aIgnacio Faushttps://www.nflbiosciences.com

NFL Biosciences SA, a biotechnology company, develops natural addiction withdrawal solutions for smokers. The company’s natural drug candidate in pipeline to cure tobacco addiction include NFL-101, a tobacco extract that is in Phase III clinical trial targeting smoking addiction; NFL-201, a cannabis and tobacco extract, which is in preclinical stage; and NFL-301, a botanical extract (traditional Chinese medicine) that is in preclinical stage. NFL Biosciences SA was incorporated in 2006 and is based in Castelnau-le-Lez, France.

NFL Biosciences SA Fundamentals Summary

How do NFL Biosciences's earnings and revenue compare to its market cap?
ALNFL fundamental statistics
Market cap€22.86m
Earnings (TTM)€0
Revenue (TTM)n/a

n/a

P/E Ratio

n/a

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ALNFL income statement (TTM)
Revenue€0
Cost of Revenue€0
Gross Profit€0
Other Expenses€0
Earnings€0

Last Reported Earnings

n/a

Next Earnings Date

Mar 29, 2024

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did ALNFL perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.